Related Experiment Video
Updated: Aug 9, 2026
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Ginsenoside Rg1 promotes skin flap survival by alleviating mitochondrial oxidative stress and apoptosis via the
Hebin Pan1, Panshen Xu1, Kaitao Wang1
1Department of Hand and Plastic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, The Second School of Medicine, Wenzhou Medical University, Wenzhou, 325000, China.
Background:
Ischemic necrosis remains a critical challenge in flap transplantation, often leading to postoperative complications and surgical failure. Ginsenoside Rg1, a bioactive component of Panax ginseng Meyer, has demonstrated protective effects against ischemia in various tissues. This study endeavors to explore whether Rg1 mitigates mitochondrial oxidative stress and apoptosis to enhance flap survival, and investigates the underlying mechanisms.
Materials And Methods:
Male rats' McFarlane flap models were established and randomly divided into sham, control, low-dose Rg1, medium-dose Rg1, and high-dose Rg1 groups. On the seventh day postoperative, flap necrosis rate and blood perfusion were evaluated. Western blotting was used to detect mitochondrial stress proteins, apoptosis and inflammation-related molecules, and angiogenesis pathway activity. In vitro, human umbilical vein endothelial cells (HUVECs) were used to simulate ischemia-reperfusion injury for analyzing oxidative stress, mitochondrial function and apoptosis rate.
Results:
Rg1 treatment dose-dependently enhanced flap survival, attenuated neutrophil infiltration and promoted angiogenesis. At the cellular level, Rg1 promoted viability and migration capacity of HUVECs while diminishing the accumulation of ROS. Furthermore, Rg1 regulated mitochondrial dynamics by upregulating fusion protein Mfn2 and downregulating fission protein Drp1, thereby inhibiting apoptosis. Western blot analysis revealed that Rg1 bidirectionally modulated the JNK/ERK/p38 pathway, suppressing pro-apoptotic signals (p-JNK, p-p38) and activating pro-survival signals (p-ERK). Additionally, Rg1 promoted angiogenesis by upregulating VEGF, Ang-1, and PDGFR-β, and reduced inflammation by suppressing IL-1β, IL-6, and TNF-α.
Conclusion:
Ginsenoside Rg1 regulates the JNK/ERK/p38 signaling pathway, mitigates mitochondrial oxidative stress and suppresses apoptosis, establishing a novel therapeutic target for flap necrosis prevention.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
